Bio-Rad (BIO) Reports Q4 Profit of $720M, EPS $2.51; Y/Y Turnaround

Bio-Rad Laboratories Inc. (BIO) reported fourth-quarter net income of $720 million, a turnaround from a loss in the same period last year. Per-share profit reached $26.65, with non-GAAP adjusted earnings of $2.51 per share. Revenue for the quarter totaled $693.2 million. For the full year, net income was $759.9 million, or $27.85 per share, and revenue amounted to $2.58 billion. Shares fell 3.5% YTD; at press time on February 12, 2026, the stock closed at $292.42, reflecting a 6% decline over the past 12 months.